MedTech Impact Partners Grows Regulatory Support Expertise

MedTech Impact Partners is pleased to announce that Marie Rigley has joined our regulatory support team as a Senior Regulatory Associate.  Marie Rigley has more than a decade of experience as a regulatory professional supporting and advising medical device companies. She has led successful FDA engagements and interactions by leveraging her  scientific background to quickly grasp a wide variety of therapeutic areas and technologies with the goal of developing and implementing strategic regulatory objectives while simultaneously meeting evolving business needs. Marie specializes in cardiovascular, respiratory, surgical implants, face masks and more. She will work with MIP clients to craft strategy for pre-submissions and 510(k) submissions for various medical devices.

Marie Rigley, Senior Regulatory Associate

 

"I am thrilled about joining the MIP team. The prospect of working alongside Kwame Ulmer and learning from his industry-leading expertise is such an excellent opportunity. I look forward to engaging in ongoing initiatives that contribute to a positive impact on the future of our MedTech clients."

Marie’s expertise complements the wide range of FDA and industry experience across MedTech Impact Partners’ team. Our regulatory consulting services can be found here. In addition, our online Insights offers a comprehensive collection of publications and perspectives from our experts on current issues in FDA regulation and policy.


About Medtech Impact Partners “Talk to the FDA before you talk to the FDA.”

MedTech Impact Partners is a leader in regulatory strategy and support. Built on decades of government and private sector experience, our services position clients to get innovative health technologies to market faster.

Our team of consultants guide MedTech companies over regulatory hurdles at the FDA, helping them deliver on key milestones and protect their bottom line. MIP’s customized approach and suite of services focus on developing sound regulatory strategy, diligent review, and managing risks for clients. 

Previous
Previous

Unlocking Insights with Kwame Ulmer: A Journey Through MedTech, FDA, and Venture Capital

Next
Next

CellKey Partnership Poised to Reshape Bioanalytical Research